rs376872829
|
|
Multiple Endocrine Neoplasia Type 1
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
|
27854360 |
2017 |
rs376872829
|
|
Multiple Endocrine Neoplasia Type 1
|
|
0.800 |
GeneticVariation
|
UNIPROT |
ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing.
|
25356965 |
2015 |
rs376872829
|
|
Multiple Endocrine Neoplasia Type 1
|
|
0.800 |
GeneticVariation
|
UNIPROT |
A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
|
25394175 |
2015 |
rs376872829
|
|
Multiple Endocrine Neoplasia Type 1
|
|
0.800 |
GeneticVariation
|
UNIPROT |
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
|
23788249 |
2013 |
rs376872829
|
|
Multiple Endocrine Neoplasia Type 1
|
G |
0.800 |
GeneticVariation
|
CLINVAR |
MEN1 is a melanoma tumor suppressor that preserves genomic integrity by stimulating transcription of genes that promote homologous recombination-directed DNA repair.
|
23648481 |
2013 |
rs376872829
|
|
Multiple Endocrine Neoplasia Type 1
|
G |
0.800 |
GeneticVariation
|
CLINVAR |
Menin missense mutants encoded by the MEN1 gene that are targeted to the proteasome: restoration of expression and activity by CHIP siRNA.
|
22090276 |
2012 |
rs376872829
|
|
Multiple Endocrine Neoplasia Type 1
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).
|
22723327 |
2012 |
rs376872829
|
|
Multiple Endocrine Neoplasia Type 1
|
|
0.800 |
GeneticVariation
|
UNIPROT |
American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
|
20065170 |
2010 |
rs376872829
|
|
Multiple Endocrine Neoplasia Type 1
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors.
|
15604628 |
2004 |
rs376872829
|
|
Multiple Endocrine Neoplasia Type 1
|
G |
0.800 |
GeneticVariation
|
CLINVAR |
The 32-kilodalton subunit of replication protein A interacts with menin, the product of the MEN1 tumor suppressor gene.
|
12509449 |
2003 |
rs376872829
|
|
Multiple Endocrine Neoplasia Type 1
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Guidelines for diagnosis and therapy of MEN type 1 and type 2.
|
11739416 |
2001 |
rs376872829
|
|
Multiple Endocrine Neoplasia Type 1
|
G |
0.800 |
GeneticVariation
|
CLINVAR |
Differential binding of the Menin tumor suppressor protein to JunD isoforms.
|
11221882 |
2001 |
rs376872829
|
|
Multiple Endocrine Neoplasia Type 1
|
G |
0.800 |
GeneticVariation
|
CLINVAR |
Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription.
|
9989505 |
1999 |
rs376872829
|
|
Multiple Endocrine Neoplasia Type 1
|
G |
0.800 |
GeneticVariation
|
CLINVAR |
Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states.
|
9215689 |
1997 |